Drug Trial Radar · NCT00285519
Japan Morning Surge-1 Study
Last checked: Nov 19, 2026Latest source record: Feb 2, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Actual
Start
Aug 2003
Primary completion
Not stated
Study completion Aug 2005
Sponsor
- Lead sponsor
- Japan Heart FoundationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 2, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 0 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to examine whether strict blood pressure (BP) control by doxazosin using home BP monitoring, especially targeting the morning BP level, can reduce hypertensive target organ damage.
Conditions
- Hypertension
Interventions
Doxazosin (drug)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- brain natriuretic peptide and the urinary albumin excretion/creatinine ratio at 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine
Shimotsuke, Tochigi, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.